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Abstract Changes in plasma aromatic amino acids
(AAA = phenylalanine, tryptophan, tyrosine) and bran-
ched chain amino acids (BCAA = isoleucine, leucine,
valine) levels possibly influencing intracranial pressure
(ICP) and cerebral oxygen consumption (SjvO2) were
investigated in 19 sedated patients up to 14 days following
severe traumatic brain injury (TBI). Compared to 44 heal-
thy volunteers, jugular venous plasma BCAA were signif-
icantly decreased by 35% (p \ 0.001) while AAA were
markedly increased in TBI patients by 19% (p \ 0.001).
The BCAA to AAA ratio was significantly decreased by
55% (p \ 0.001) which persisted during the entire study
period. Elevated plasma phenylalanine was associated with
decreased ICP and increased SjvO2, while higher plasma
isoleucine and leucine levels were associated with increased
ICP and higher plasma leucine and valine were linked to
decreased SjvO2. The amount of enterally administered
amino acids was associated with significantly increased
plasma levels with the exception of phenylalanine. Contrary
to the initial assumption that elevated AAA and decreased
BCAA levels are detrimental, increased plasma phenylala-
nine levels were associated with beneficial signs in terms of
decreased ICP and reduced cerebral oxygen consumption
reflected by increased SjvO2; concomitantly, elevated
plasma isoleucine and leucine levels were associated with
increased ICP while leucine and valine were associated with
decreased SjvO2 following severe TBI, respectively. The
impact of enteral nutrition on this observed pattern must be
examined prospectively to determine if higher amounts of
phenylalanine should be administered to promote beneficial
effects on brain metabolism and if normalization of plasma
BCAA levels is without cerebral side effects.
Keywords Critical care  Monitoring  Neuromonitoring 
Nutrition
Introduction
Following traumatic brain injury (TBI) a cascade of sec-
ondary events, including, among others, amino acid-med-
iated excitotoxicity, may promote secondary brain edema
formation with consecutive clinical deterioration and
increased intracranial pressure (ICP). Consequently, pre-
vention of secondary brain damage is the main therapeutic
target in contemporary intensive care treatment (Stover
et al. 2005). In this context, diminished SjvO2 reflects
cerebral metabolic impairment and insufficient cerebral
perfusion (Robertson et al. 1995).
Stressful events are associated with significant increases
in plasma aromatic amino acids (AAA), i.e., phenylalanine
(Phe), tryptophan (Trp) and tyrosine (Tyr) and significant
decreases in branched chain amino acids (BCAA), i.e.,
valine (Val), leucine (Leu) and isoleucine (Ile) (Freund
et al. 1978, 1979, 1982; Stinnett et al. 1982; Vente et al.
1989; Basler et al. 2002; Blomstrand et al. 2005; Dejong
et al. 2007).
Imbalances between plasma BCAA and AAA levels are
known to contribute to metabolic encephalopathy as
observed following liver failure. In this context, Tyr and Phe
enhance synthesis of physiologic excitatory adrenergic
neurotransmitters (dopamine, norepinephrine, and epineph-
rine) (Fernstrom and Fernstrom 2007) and so-called false
neurotransmitters (phenylethanolamine and octopamine)
which may also mediate neuronal excitation (Cangiano
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et al. 1982). Tyr promotes serotonin synthesis (Fernstrom
and Fernstrom 2007; Daubert and Condron 2010).
Since AAA and BCAA compete for the same amino
acid transporter within the BBB, a reduction in BCAA
plasma levels further increases cerebral AAA uptake.
Sustained cerebral AAA uptake with subsequent increased
synthesis of excitatory amino acids could promote exces-
sive neuronal excitation. This, in turn, could facilitate
metabolic impairment reflected e.g., by decreased SjvO2
and result in sustained edema formation unmasked e.g., by
increased ICP. Whether TBI patients also show an imbal-
ance between AAA and BCAA and if changes in plasma
AAA and BCAA concentrations are possibly associated
with increased cerebral oxygen consumption and elevated
ICP, thereby expanding contemporary neuromonitoring
(Stover 2011) has not been investigated yet.
To test the hypothesis that changes in plasma AAA and
BCAA influence SjvO2 and ICP we performed the current
retrospective analysis. In addition, we investigated if the
composition of an enteral nutrition solution as used in
clinical routine influences plasma AAA and BCAA. For
this, we measured plasma concentrations of AAA (Phe, Trp
and Tyr) and BCAA (Ile, Leu and Val) in 19 TBI patients
subjected to pharmacologic coma for up to 2 weeks. The
plasma amino acid levels were compared to the results
obtained in 44 healthy volunteers. Influence of enteral
nutrition on plasma AAA and BCAA levels was assessed
by linear regression analysis. Possible pathologic impact of
changes in AAA and BCAA values was assessed by cor-
relation with ICP and SjvO2 values.
Materials and methods
This study was approved by the local ethics committee and
written informed consent was obtained by the relatives of
the TBI patients and the volunteers, respectively.
Patients with severe traumatic brain injury
Following TBI jugular venous plasma was collected daily
up to 14 days. For this, a catheter was inserted in the
internal jugular vein with the tip positioned in the jugular
bulb of the dominant internal jugular vein. The correct
localization was verified by lateral X-ray of the skull. A
total of 121 plasma samples were collected. Patients older
than 65 and younger than 16 years were excluded as well
as patients with a known history of seizure disorders,
depression, alcohol or drug abuse, renal or hepatic dys-
function, metabolic disorders or previous history of TBI.
Patients suffering from severe abdominal injury requiring
surgery or constipation, in whom enteral nutrition could not
be performed, those who were anticipated to die within the
first 24 h, and patients in need of barbiturate coma to treat
intractable intracranial hypertension were not included.
TBI patients were treated using a standardized treatment
protocol as reported previously (Vuille-Dit-Bille et al.
2011). For sedation and analgesia, midazolam (Dormi-
cum) and fentanyl (Sintenyl) were infused continuously.
Cerebral perfusion pressure (CPP) was maintained above
60 mmHg by infusing norepinephrine and crystalloids or
colloids. Ventilation and oxygenation were guided by
SjvO2 maintained above 60%. TBI patients did not receive
heparin or low molecular weight heparin (LMWH).
All patients were fed enterally according to our stan-
dardized protocol using Jevity Plus (Abbott, Abbott Park,
IL, 60064-3500, USA) which was started with 20 ml/h
within the first 12 h and increased by 10 ml/h every 6 h,
reaching target volume and calories within 30 h. Individual
dose was adjusted to meet caloric requirement determined
by indirect calorimetry which was performed twice every
week. According to the manufacturer’s manual Jevity
Plus contains Phe 2,700 mg/l, Tyr 2,700 mg/l, Trp 60 mg/l,
Ile 2,500 mg/l, Leu 4,900 mg/l, and Val 3,100 mg/l, with an
increased BCAA to AAA ratio (1.9:1).
Healthy volunteers
A total of 44 volunteers (22 males, 22 females, aged
mean ± SD 37.2 ± 10.4, range 22–56 years) were included
in this study. Blood was drawn once from the cubital vein in
the morning between 8:00 a.m. and 09:00 a.m. after over-
night fasting. Volunteers with recent history of fever, surgery
or drug intake (e.g., antibiotics, anti-depressants, sedatives,
analgetics, platelet aggregation inhibitors) were excluded.
Analysis of plasma amino acids and calculation
of Fischer ratio
Jugular venous blood was drawn in the morning between
8:00 a.m. and 09:00 a.m. during enteral nutrition, compa-
rable to healthy volunteers to correct for possible circadian
changes.
In addition to jugular venous plasma, arterial plasma
was also analyzed at the same time points. However,
arterial–jugular venous differences were not significant;
since arterial blood had not been drawn from the volun-
teers, the patients’ arterial results are not presented.
Concentrations of amino acids were determined by high
performance liquid chromatography (HPLC) as reported
previously (Vuille-Dit-Bille et al. 2011).
The calculated BCAA to AAA ratio, referred to as the
Fischer ratio (Fischer et al. 1976; Miyazaki et al. 2003) is
widely used to assess amino acid-related metabolic
encephalopathy as found e.g., in hepatic dysfunction. The
Fischer ratio was calculated by dividing the sum of BCAA,
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i.e., Ile, Leu, and Val through the sum of Phe and Tyr. With
increasing plasma Phe and Tyr levels, the Fischer ratio will
decrease while elevated BCAA levels will increase the
calculated Fischer ratio.
Treatment of patients was not influenced by this study or
hereby obtained results.
Statistical analysis
Results are shown as mean ± SD (standard deviation).
Differences between groups were analyzed using unpaired
students t test or one-way analysis of variance (ANOVA)
with post hoc multiple comparison. Correlation was
performed by linear regression analysis. Changes were
considered significant at p values \0.05. Graphic and sta-
tistical analysis was performed using SigmaPlot10 (Systat
Software Inc).
Results
Patient data and impact of additional injuries
and complications on plasma amino acid levels
A total of 19 patients consisting of 17 males and two
females, of whom nine presented with isolated TBI were
included in this study (Table 1). Plasma amino acid levels
were not influenced by the additional injuries and com-
plications observed during the 14-day observational period
(data not shown). Treatment measures determined by the
therapy intensity level taken to lower increased ICP were
similar in both weeks (Table 1).
Changes in plasma branched chain amino acids
Compared to healthy controls, plasma Ile, Leu, and Val
concentrations were significantly decreased during the first
week following severe TBI. During the second posttrau-
matic week, BCAA levels showed a non-significant trend
to higher values with Leu and Val remaining significantly
decreased compared to healthy volunteers (Fig. 1a).
Changes in plasma aromatic amino acids
Compared to healthy controls, plasma Tyr was significantly
increased during both posttraumatic weeks; Phe was sig-
nificantly increased during the first posttraumatic week and
Trp showed a non-significant trend to higher values over
time (Fig. 1b).
Changes in calculated arterial–jugular venous
differences
Calculated arterial–jugular venous differences in plasma
amino acids were not significantly changed over time or
influenced by the enteral nutrition (data not shown).
Influence of enteral nutrition on plasma amino acid
concentrations
All patients received Jevity Plus as our standard enteral
nutrition (Table 2). In the second week, patients received
significantly higher amount of enteral nutrition, thereby
resulting in significantly more calories (Table 2). On
average, patients received 23 kcal/kg/day in the second
week compared to 19 kcal/kg/day during the first week
(Table 2).
With the specific composition of Jevity Plus, patients
received on average Phe 3325 ± 128 mg/day, Tyr 3324 ±
128 mg/day, Trp 74 ± 3 mg/day, Ile 3078 ± 118 mg/day,
Leu 6034 ± 232 mg/day, and Val 3817 ± 147 mg/day,
respectively.
While plasma Tyr [Tyr = 43.428 ? (0.0194 9 Jevity)
R2 = 0.129; p \ 0.0001], Trp [Trp = 30.993 ? (0.00979 9
Jevity), R2 = 0.07; p = 0.004], Ile [Ile = 23.839 ?
(0.0113 9 Jevity), R2 = 0.136; p \ 0.001], Leu [Leu =
77.286 ? (0.0160 9 Jevity), R2 = 0.079; p = 0.002], and
Val [Val = 105.149 ? (0.0386 9 Jevity), R2 = 0.144;
Table 1 Demographic data of the investigated 19 patients suffering
from severe traumatic brain injury requiring continuous pharmaco-
logic coma and receiving standard enteral nutrition with Jevity Plus
Age (mean ± SD; median,
range)
39.2 ± 13.0 (41, 18–64)
Gender (female/male) 2/17 (89/11%)
GCSi 9 ± 4 (9, 3–15)
AIS head 4.8 ± 0.5 (5, 3–5)
ISS excluding AIS head 6.5 ± 7.8 (3, 0–20)
9 isolated TBI
2 thoracic injury and femur fracture
1 combined abdominal and thoracic
injury
1 abdominal injury and femur
fracture
4 humerus fractures
2 pelvis fractures
Days on ICU 24 ± 14 (21, 6–54)
Complications 8 pneumonia
2 urinary tract infections
eGOS at 6 months 5.8 ± 1.8 (6, 2–8)
Results are given as mean ± standard deviation with median and
range
ICU intensive care unit, eGOS extended Glasgow Outcome Scale,
GCSi initial Glasgow Coma Scale, AIS abbreviated Injury Score, ISS
Injury Severity Score
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p \ 0.001] correlated significantly with the enterally
administered amino acids, there was no significant corre-
lation for plasma Phe (Fig. 2).
Branched chain and aromatic amino acids and SjvO2
Within the group of BCAA, elevated plasma Leu and Val
levels significantly correlated with low SjvO2 (Fig. 3).
Within the group of AAA, higher Phe significantly corre-
lated with elevated SjvO2. Tyr, Trp, and Ile had no sig-
nificant effect on SjvO2.
Branched chain and aromatic amino acids and ICP
Increased plasma Ile and Leu significantly correlated
with elevated ICP (Fig. 4) while increased plasma Phe
correlated significantly with lower ICP. Tyr, Trp, and Val
had no significant effect on ICP.
Calculated Fischer ratio in patients and healthy
volunteers
Fischer ratio reflecting imbalance between (Leu ?
Ile ? Val)/(Phe ? Tyr) remained significantly lower in
TBI patients at all time points compared to healthy vol-
unteers: 2.7 ± 0.8 (week 1), 3.1 ± 0.2 (week 2) versus
6.5 ± 0.1 (p \ 0.0001) (volunteers).
Correlation of calculated Fischer ratio with ICP
and SjvO2
Increased calculated Fischer ratio correlated significantly
with high ICP and significantly with low SjvO2 (Fig. 5).
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Fig. 1 Changes in branched chain amino acids and aromatic amino
acids during the first two posttraumatic weeks in 19 sedated patients
with severe traumatic brain injury represented as box plots (solid line
median, dashed line mean, box limits 25th and 75th percentile,
whiskers 5th and 95th percentile). Plasma Ile, Leu, and Val levels
were significantly decreased compared to healthy volunteers
(p \ 0.001, ANOVA with post hoc Dunn’s test). Plasma Phe and
Tyr were significantly increased compared to healthy controls
(p \ 0.001, ANOVA with post hoc Dunn’s test). There were no
significant differences between the first and second week
Table 2 Changes in intracranial pressure (ICP), cerebral perfusion pressure (CPP), paCO2, temperature, and enteral nutrition during the first
2 weeks in 19 patients with severe traumatic brain injury
week 1 week 2
ICP (mmHg) 15 ± 5 (15, 6–27) 18 ± 4 (19, 12–27)
CPP (mmHg) 82 ± 5 (82, 66–97) 80 ± 8 (80, 71–114)
paCO2 (kPa) 4.95 ± 0.7 (5, 4.2–5.8) 4.86 ± 0.8 (4.9, 4–5.6)
Temperature (C) 35.7 ± 0.9 (35.5, 34.4–36.7) 35.5 ± 0.6 (35.8, 34.9–36.6)
Therapy intensity level (TIL) 2 ± 0.8 (2.6, 2–4) 2 ± 0.8 (2.7, 2–4)
Jevity Plus (ml/day) 1,183 ± 498 (1,300, 60–2,200) 1,444 ± 476* (1,550, 150–2,300)
kcal/day 1420 ± 590 (1,560, 72–2,640) 1,733 ± 490 (1,860, 180–2,760)*
Average kcal/kg/day 19 23*
In the second week, the patients received significantly more calories, reflected by significantly increased amount of Jevity Plus (*p \ 0.02,
Mann–Whitney test). Results are given as mean ± standard deviation with median and range
1290 R. N. Vuille-Dit-Bille et al.
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Changes in arterial blood glucose and insulin
administration
During the first 2 weeks, arterial blood glucose remained
within the pre-defined target 3.5–6.5 mmol/l without a
significant difference between the first and second week
(Table 2).
Insulin administration was similar during the first two
posttraumatic weeks without a significant difference
(Table 2).
Plasma amino acids were not influenced by the changes
in blood glucose or insulin (data not shown).
Discussion
Following severe TBI, plasma BCAA were significantly
decreased while AAA were markedly increased. The
resulting significantly decreased Fischer ratio persisted
during the first two posttraumatic weeks. While elevated
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(0.0160 9 Jevity), R2 = 0.08, p = 0.002] and plasma Tyr
[Tyr = 43.428 ? (0.0194 9 Jevity), R2 = 0.129, p \ 0.001] repre-
senting the changes in branched chain amino acids and aromatic
amino acids, respectively, was encountered at higher amounts of
enterally administered Jevity 1.5 cal
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Fig. 3 SjvO2 was significantly decreased at elevated plasma Leu and
Val levels [SjvO2 = 77.798 - (0.0482 9 Leu); R
2 = 0.0494, p =
0.018, SjvO2 = 77.262 - (0.0302 9 Val), R
2 = 0.0628, p = 0.022]
while SjvO2 was significantly increased at higher plasma Phe
concentrations [SjvO2 = 65.836 ? (0.155 9 Phe), R
2 = 0.0940, p \
0.001. Plasma Tyr, Trp, and Ile showed no significant effect on SjvO2
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Fig. 4 ICP was significantly decreased at elevated plasma Phe
[ICP = 20.792 - (0.102 9 Phe), R2 = 0.0583, p = 0.010] while
ICP was significantly increased at higher plasma Ile [ICP = 13.115 ?
(0.0747 9 Ile); R2 = 0.0489; p = 0.021] and Leu [ICP = 12.601 ?
(0.0341 9 Leu), R2 = 0.0357, p = 0.047]
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plasma Phe was associated with significantly decreased
ICP, higher plasma Ile and Leu were associated with sig-
nificantly increased ICP. Concomitantly, elevated plasma
Phe was associated with significantly increased SjvO2
while higher plasma Leu and Val levels were associated
with markedly decreased SjvO2. The plasma pattern was
influenced by the enterally administered amino acids.
Cautious interpretation of this pattern suggests that (1)
increased plasma BCAA levels might exert disadvanta-
geous effects following severe TBI, (2) higher plasma Phe
levels might be advantageous, and (3) enteral nutrition
influences the plasma pattern.
Importance of branched chain amino acids
BCAA, especially leucine is an important regulator of
protein synthesis (Avruch et al. 2009). BCAA promote
ammonia detoxification, correct plasma amino acid
imbalance, attenuate cerebral AAA influx, improve protein
synthesis, glutamine production and inhibit proteolysis
(Holecek 2010). In addition, BCAA support cardiac and
skeletal muscle mitochondrial biogenesis, prevent oxida-
tive damage, and enhance physical endurance (Valerio
et al. 2011). Independent of hepatic encephalopathy plasma
Leu, Ile, and Val levels also influence brain function by
promoting glutamate compartmentalization, energy syn-
thesis and most importantly by balancing the uptake of
AAA, thereby controlling subsequent synthesis of excit-
atory monoaminergic neurotransmitters dopamine, nor-
adrenaline, adrenaline, and serotonin from the AAA
precursors Tyr and Trp, respectively (Fernstrom 2005).
Under normal conditions, BCAA and AAA are transported
by the same amino acid transporter (LAT1) across the
BBB, which is nearly fully saturated at physiologic plasma
amino acid concentrations (Meier et al. 2002; Verrey
2003). In addition, BCAA improve recovery of cognition in
a posttraumatic vegetative or minimally conscious state,
most likely by increasing cerebral energy production,
restoring ionic homeostasis, reducing membrane depolar-
ization and attenuating neuronal injury, mostly in ischemic
regions (Aquilani et al. 2005). However, oral ingestion of
BCAA has been associated with neuropsychologic altera-
tions related to reduced brain catecholamine synthesis and
brain dopamine function (Scarna` et al. 2005).
In the present study, plasma BCAA levels were signifi-
cantly decreased during the first posttraumatic week com-
pared to healthy volunteers. Over time, the BCAA showed a
different temporal profile: while Ile levels showed a trend to
normalization in the second week, plasma Leu and Val
concentrations remained significantly decreased. The per-
sisting decrease in BCAA which occurred despite enteral
nutrition contributed to a significant decrease in the calcu-
lated Fischer ratio maintained during the entire study period.
This pattern is not specific for TBI but typical for critically ill
patients (Freund et al. 1978, 1979, 1982; Vente et al. 1989;
Basler et al. 2002; Dejong et al. 2007) which is not
encountered in patients undergoing elective surgery
(Askanazi et al. 1980a, b). Contrary to our present results,
Petersen et al. (1996) could not show significant differences
in the calculated Fischer ratio despite a significant decrease
in all amino acids by 46%. One possible reason could be the
very aggressive nutritional strategy with 30 kcal/kg chosen
by Petersen and coworkers compared to the slow increase in
nutritional/caloric support as performed in our patients with
an average of 19 kcal/kg/day during the first week gradually
increased to 23 kcal/kg/day in the second week. Unfortu-
nately, Petersen and coworkers used different nutrition
products without providing sufficient information as to their
administration (Vital HN, Ross Laboratories; and Jevity,
Ross Laboratories). Suzuki et al. (2002) investigated the
changes in plasma amino acids during the first 24 h fol-
lowing TBI without, however, specifically addressing
alterations in BCAA and AAA and without statistical com-
parison to blood samples taken from 101 healthy volunteers.
To date, the impact of an altered Fischer ratio following
severe TBI has not been investigated. The present study is
the first to unmask significant changes which also appear to
be of functional relevance. In this context, linear regression
analysis revealed a direct impact of plasma BCAA on ICP
values and an indirect correlation with SjvO2 levels fol-
lowing severe TBI. These changes were mainly induced by
Ile and Leu associated with increased ICP and Leu- and
Val-associated decrease in SjvO2 values. These results
suggest a more disadvantageous effect of BCAA compared
to Phe which was associated with decreased ICP and
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Fig. 5 SjvO2 was significantly and inversely influenced by calculated
Fischer ratio [SjvO2 = 79.820 - (2.733 9 FR), R
2 = 0.127, p =
0.001]. ICP was significantly influenced by the calculated Fischer
ratio [ICP = 13.527 ? (1.324 9 FR), R2 = 0.0987, p = 0.005]
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increased SjvO2 values. Lower SjvO2 levels coinciding
with higher Leu and Val levels suggest increased cerebral
oxygen consumption possibly induced activation of protein
synthesis, transport and uptake processes, and ammonia
detoxification (Holecek 2010). Cerebral hypoxia/ischemia
due to insufficient cerebral oxygenation, impaired CPP, or
sustained hyperventilation can be excluded (Table 2), as
SjvO2 remained above the ischemic threshold of 50% and
the other parameters were within pre-defined target range.
This, in turn, favors an amino acid-driven influence. Sus-
tained cerebral oxygen consumption and Leu-driven
increased cerebral CO2 production (Chaplin et al., 1976)
could result in increased cerebral vasodilation which, in
turn, might explain the increased ICP at higher Ile and Leu
levels. The present data does not allow to determine a
possible Ile-, Leu- and Val-mediated edema-aggravating
effect. However, length hospitalization, indirectly reflect-
ing emerging complications, was not significantly influ-
enced by these amino acids (linear regression analysis, data
not shown). With the dose-dependent influence of amino
acids provided by enteral nutrition on plasma concentra-
tions, we could hypothesize that enteral nutrition could
influence amino acid-mediated changes in ICP and SjvO2.
This, however, must be investigated prospectively.
Importance of aromatic amino acids (AAA)
In the present study, plasma Tyr was increased during the
first two posttraumatic weeks while Phe was only signifi-
cantly increased during the first week. Physiologic as well
as pathophysiologic effects of increased plasma AAA
levels depend on the balancing effects mediated by BCAA
(Fernstrom and Fernstrom 2007). Under physiologic con-
ditions, Phe and Tyr are the precursors for subsequent
synthesis of the excitatory neurotransmitters noradrenaline,
adrenaline, and dopamine (Fernstrom and Fernstrom 2007).
As shown in soldiers investigated under stressful condi-
tions increased plasma Tyr levels reached during a tyro-
sine-enriched diet increased cerebral catecholamine
synthesis, thereby promoting catecholamine-dependent
effects, including regulation of blood pressure, thermo-
regulation as well as improved cognition and performance
(Fernstrom 2000, Lieberman 2003). Transport of AAA and
BCAA across the luminal and basolateral membrane of the
BBB (Roberts et al. 2008) is mediated by the same large
high affinity (Km 15–50 lM) transporter LAT1 for neutral
amino acids (Meier et al. 2002; Verrey 2003). Due to the
competition of different neutral amino acids for LAT1-
mediated transport, increases in plasma levels of one single
amino acid may decrease cerebral uptake of other amino
acids (Fernstrom and Fernstrom 2007) which as e.g., in
phenylketonuria disturbs brain development (Blau et al.
2010). BCAA-rich diets which competitively reduce
cerebral uptake of Tyr and Phe were associated with
reduced dopamine synthesis and depression of different
physiological and behavioral effects, including spatial
recognition memory and physical performance (Scarna`
et al. 2005, Fernstrom and Fernstrom 2007).
Sustained cerebral synthesis of AAA-derived excitatory
neurotransmitters can promote transmitter-induced
encephalopathy (Fernstrom 2005) which is feared to
aggravate underlying traumatic brain damage due to aug-
mented vulnerability. In addition, AAA-promoted synthe-
sis of ‘‘false neurotransmitters’’ such as octopamine,
phenylethanolamine, and tyramine are also associated with
encephalopathic changes (Holecek 2010). Contrary to these
potentially disadvantageous effects due to increased
plasma AAA levels, linear regression analysis excluded
signs of significant cerebral worsening: while Tyr and Trp
showed no effect under the present conditions, elevated
plasma Phe levels were associated with decreased ICP and
increased SjvO2. In fact, the present study even suggests
positive effects related to increased plasma Phe. Whether
this is induced by the enteral nutrition must be investigated
prospectively.
Possible impact of enteral nutrition on plasma amino
acid levels
The present retrospective analysis shows that increased
supply of enterally administered amino acids was associated
with a significant increase in plasma BCAA and Tyr, and
Trp with the exception of Phe. Despite this dose-dependent
effect, enteral nutrition was insufficient to normalize plasma
BCAA. Thus, higher amounts of BCAA in the enteral
nutrition formula appear to be necessary. Based on the
current analysis, however, a more aggressive increase in
plasma BCAA level might be off-set by the observed
increase in ICP and decreased SjvO2 and reported neuro-
psychologic alterations (Scarna` et al. 2005, Fernstrom and
Fernstrom 2007). A prospective study is required to identify
the required dose and assess possible dose dependent
BCAA-mediated effects on ICP and SjvO2. As suggested by
the current plasma profile it does not appear necessary to
increase the amount of AAA in the enteral nutrition formula
as plasma AAA levels were comparable to healthy volun-
teers and even significantly increased over time. However,
the present data showing a beneficial impact of Phe reflected
by decreased ICP and increased SjvO2 suggest that an
increase in plasma Phe levels might be useful. This
hypothesis must be investigated in a prospective study.
Persistently decreased plasma amino acid levels
As reported by Aquilani et al. (2003) and Borsheim et al.
(2007), plasma amino acid levels remain decreased during
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the posttraumatic rehabilitation phase between 1 and
22 months after trauma. Based on this data, high energy
nutritional support (32.5 kcal/kg) maintained or improved
the patients’ nutritional status without, however, correcting
plasma amino acid imbalances. This, in turn, suggests to
adapt the composition of the nutritional support based on
the individual plasma levels to correct underlying defi-
ciency (Aquilani et al. 2003) which is in line with results
published by Borsheim et al. (2007) showing that persis-
tently decreased amino acids as e.g., valine can be signif-
icantly increased by oral supplementation. Whether the
significantly elevated plasma amino acid levels achieved
by day 14 in the presently investigated TBI patients per-
sisted thereafter and improved neurologic recovery during
the rehabilitation phase cannot be determined by the
present study. Prospective studies are required to identify
an optimal composition of the enteral (and parenteral)
nutrition to convey beneficial changes during the early
posttraumatic and rehabilitative phase. In this context,
optimized nutritional support could improve neuropsy-
chologic recovery and decrease rate of depression and
posttraumatic parkinsonism due to increased cerebral
serotonin and cerebral dopamine synthesis by elevating
plasma Trp, Tyr and Phe levels and increasing cerebral
Trp, Tyr and Phe uptake, respectively. In addition,
improved muscle protein synthesis related to elevated
plasma and extracellular amino acid levels should facilitate
quicker physical rehabilitation (Bohe´ et al. 2003).
Study limitations and methodological considerations
Comparing jugular venous amino acids taken from patients
with peripheral venous amino acids obtained in volunteers
is difficult as peripheral venous values reflect changes in
skeletal muscle metabolism and jugular venous levels are
influenced by cerebral metabolism. For technical reasons,
however, cannulation of peripheral veins in patients is
difficult due to peripheral edema and an increased risk of
phlebitis which will off-set repetitive measurements and
impair adequate interpretation of dynamic changes over
time. More detailed investigations aimed at assessing the
release and uptake of amino acids from skeletal muscle of
the arm in these sedated critically ill patients are necessary
to determine if amino acids taken from the cubital vein can
be used as a reference values for jugular venous levels. In
theory, the small muscle mass of the arm in immobilized
deeply sedated patients should only marginally influence
the peripheral venous levels. The fact that volunteers did
not agree to arterial blood sampling does not allow to
assess the influence of muscle metabolism reflected by
changes in blood taken from the radial artery in patients.
However, arterial plasma taken from femoral artery as
performed in daily routine does not allow interpretation of
the influence of muscle on changes determined in cubital
venous blood. Separate investigations requiring arterial and
internal jugular venous and peripheral venous cannulation
in healthy volunteers are required to address the funda-
mental issue of possible site-specific differences in blood
amino acid composition.
The difference in feeding state, i.e., overnight fasting
in healthy volunteers living on their regular protein-based
diet compared to continuous enteral nutrition in patients
might also account for the observed significant differ-
ences. As shown by Riggio et al. (1989), the presently
observed increase in venous plasma leucine, isoleucine,
and valine levels in healthy volunteers could imply a lack
in protein intake. However, the simultaneous significant
decrease in plasma tyrosine, phenylalanine, and trypto-
phan levels in healthy volunteers compared to patients
investigated in the present study excludes a lack in pro-
tein ingestion from prolonged fasting. According to the
results published by Riggio et al. (1989), only prolonged
protein-free fasting exceeding 2 days will increase plasma
BCAA and AAA amino acid levels. The cubital venous
plasma BCAA and AAA levels determined in healthy
volunteers of the present study are similar to levels
reported by Riggio et al. (1989) in volunteers on a reg-
ular protein-based diet. This, in turn, suggests that the
plasma pattern observed in the presently investigated
patients reflects underlying pathophysiology e.g., related
to TBI, critical illness with its specific hormonal altera-
tions during pharmacologic coma, and continuous enteral
nutrition.
Whether increases in one subset of plasma amino acids
are balanced by the decrease in other amino acids to
maintain constant levels of overall amino acid concentra-
tions as reviewed by Feigin et al. (1971) remains unclear.
However, the fact that both plasma BCAA and AAA levels
were significantly elevated by increased enteral nutrition
excludes a compensatory mutual regulation at least in these
investigated amino acids. Regulatory influences mediated
by these amino acids on other amino acids as e.g., methi-
onine and threonine cannot be determined by the present
study (Shikata et al. 2010).
To correct for possible circadian changes with reduced
plasma levels during the morning hours following an
overnight fasting, plasma samples were drawn between
08:00 and 09:00 a.m. in healthy volunteers and patients,
respectively. Whether a normal circadian profile is pre-
served in patients subjected to pharmacologic coma is
unclear as a change in sleep-wakefulness pattern has been
shown to alter the plasma amino acid rhythmicity as
reviewed by Feigin et al. (1971).
Detailed possible impact of dynamic changes in
underlying treatment effects on ICP and CPP cannot be
assessed by the present investigations. To minimize potential
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interferences, patients requiring barbiturates and aggressive
cooling were excluded. On average, ICP, CPP and paCO2
were comparable during the first and second week
(Table 2). The therapy intensity level was similar in both
weeks, excluding dramatic worsening requiring most
aggressive treatment options as e.g., barbiturate coma and
craniectomy. Owing to underlying therapeutic interven-
tions, ICP was predominantly maintained below 20 mmHg.
These interventions, in turn, might interfere with the cor-
rect interpretation of the impact of BCAA and AAA on ICP
and SjvO2. Based on the observed significant influence of
plasma amino acids on ICP and SjvO2 despite underlying
treatment effects, we may assume that this response might
have been even more obvious without the therapeutic
interventions. A detailed prospective study including larger
patient number including multiparametric analysis is
required to address the impact of enteral nutrition with its
specific amino acid composition on brain metabolism and
brain-specific parameters as e.g., ICP, SjvO2. While (Oertel
et al. (2009) were able to demonstrate significant positive
influence of protein-rich diet in neurosurgical patients
without, however, addressing the individual amino acids,
Rossetti et al. (2008) were able to show significant influ-
ence of increased plasma amino acids on cognitive func-
tions without, however, defining the impact of BCAA.
Conclusions
Critically ill patients suffering from severe TBI requiring
continuous pharmacologic coma and receiving continuous
enteral nutrition showed significantly reduced jugular
venous plasma Ile, Leu, and Val levels and significantly
increased jugular venous plasma Phe and Tyr levels com-
pared to cubital venous plasma in healthy controls. This
study suggests that enteral nutrition failed to normalize
plasma BCAA levels despite a significant dose-dependent
increase in plasma BCAA and AAA. Contrary to the initial
assumption that elevated AAA levels are detrimental, only
increased plasma Phe levels were associated with benefi-
cial signs in terms of decreased ICP and reduced cerebral
oxygen consumption reflected by increased SjvO2. In fact,
increased jugular venous BCAA levels were associated
with increased ICP and decreased SjvO2. Prospective
studies are required to determine a dose-dependent effect
of enteral nutrition on plasma amino acids and the potential
Phe- and BCAA-mediated effects as observed in the cur-
rent retrospective analysis.
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